Okay, let's tackle this question about the tuberculin test. The user wants a detailed explanation following their specific structure. First, I need to figure out what the question is really asking. The tuberculin test is a skin test used to detect tuberculosis infection. The options aren't provided, but the correct answer is likely referring to the type of test it is.

The core concept here is the mechanism of the tuberculin test. It's a delayed-type hypersensitivity reaction, which is a type IV hypersensitivity. The test uses purified protein derivative (PPD) from Mycobacterium tuberculosis. When injected intradermally, it causes a localized reaction if the person has been exposed to TB.

The correct answer would probably be something like "Type IV hypersensitivity test." The other options might be different types of hypersensitivity or other tests. For example, options could include Type I, II, or III, or mention other tests like the interferon-gamma release assays (IGRAs).

For the wrong options: Type I is IgE-mediated, like allergies. Type II involves antibodies against cell surfaces. Type III is immune complex-mediated. The tuberculin test isn't a blood test, so if an option says that, it's wrong. Also, it's not a culture or PCR test.

The clinical pearl is that the tuberculin test is a skin test for TB exposure, but it can't distinguish between latent infection and active disease. Also, people with recent TB vaccination might have a false positive.

I need to make sure each section is concise, uses proper medical terms, and fits within the character limit. Let me structure each part step by step, ensuring I address all the user's requirements.

**Core Concept**
The tuberculin test, also known as the Mantoux test, detects prior exposure to *Mycobacterium tuberculosis* by measuring a **Type IV delayed-type hypersensitivity** reaction to purified protein derivative (PPD). It is a **cell-mediated immune response** involving sensitized T-helper 1 (Th1) cells recognizing TB antigens.

**Why the Correct Answer is Right**
The test works by injecting PPD intradermally, which elicits a localized induration (not redness) within 48–72 hours. This response is mediated by memory T-cells activated upon prior TB infection or BCG vaccination. The reaction reflects **cell-mediated immunity**, not humoral immunity, and is distinct from immediate (Type I) or immune complex (Type III) hypersensitivity.

**Why Each Wrong Option is Incorrect**
**Option A:** *Type I hypersensitivity* involves IgE and mast cells (e.g., allergies) — the tuberculin test is cell-mediated.
**Option B:** *Type II hypersensitivity* involves IgG/IgM antibodies targeting cell surface antigens (e.g., hemolytic anemia).
**Option C:** *Type III hypersensitivity* involves immune complexes (e.g., serum sickness) — unrelated to TB testing.

**Clinical Pearl / High-Yield Fact**
The tuberculin test cannot distinguish active TB from latent infection or BCG vaccination. For high-risk populations, **IGRAs** (interferon-gamma release assays) like the QuantiFERON-TB Gold test are preferred as they are BCG-independent.

**Correct Answer: C.

✓ Correct Answer: B. Intradermal